Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02213588 · ClinicalTrials.gov registry record · NA

Effects of Plant Concentrate Blend on Oxidative Stress in Healthy Humans

A NA study of Healthy, sponsored by Access Business Group.

Completed
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT02213588: Completed NA study of Healthy, sponsored by Access Business Group.

NCT02213588 is a NA study of Healthy that has completed, run by Access Business Group. The registered enrollment target is 120 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02213588, a NA study of Healthy, has completed, sponsored by Access Business Group.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

This study evaluates the response to oxidative stress in healthy men and women after taking a blend of plant concentrate.

Primary Outcome

Change from baseline in urinary antioxidant biomarker in 3 months.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT AOX blend

Study Locations (1)

California

  • Southbay Pharma Research - Buena Park

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2013-07
Est. Completion 2014-08
Phase NA
Access Business Group

5 total trials

What the finished NCT02213588 record still lists

NCT02213588 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (81% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02213588 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02213588 about?

NCT02213588 is a clinical study titled "Effects of Plant Concentrate Blend on Oxidative Stress in Healthy Humans". This study evaluates the response to oxidative stress in healthy men and women after taking a blend of plant concentrate.

What is the current status of trial NCT02213588?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2013-07. Estimated completion is 2014-08.

What conditions does trial NCT02213588 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT02213588?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), AOX blend (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02213588?

This trial is sponsored by Access Business Group, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02213588 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02213588's enrollment target sits among peer trials

120 182nd of 1090 higher than 896 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02213588, the US trial registry maintained by the National Library of Medicine. NCT02213588 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.